Create an Account
  1. Home
  2. Medical News
  3. A novel approach for high CV risk patients with diabetes: The potential of epigenetics

Meeting Impression: A novel approach for high CV risk patients with diabetes: The potential for epigenetics

05/09/2016

A Meeting Impression from a EBAC accredited satellite symposium held at ESC 2016 in Rome that explored a novel approach to reduce residual CV risk, namely BET inhibition

News - Sep. 6, 2016

Download Meeting Impression in PDF

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free
    You are now leaving PACE-CME and going to a site run by another organization.

    Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.